β4-adrenoceptors are more effective than β1-adrenoceptors in mediating arrhythmic Ca2+ transients in mouse ventricular myocytes

被引:25
作者
Freestone, NS
Heubach, JF
Wettwer, E
Ravens, U
Brown, D
Kaumann, AJ [1 ]
机构
[1] Babraham Inst, Mol Signalling Lab, Cambridge CB2 4AT, England
[2] Babraham Inst, Lab Computat Neurosci, Cambridge CB2 4AT, England
[3] Tech Univ Dresden, Univ Klinikum, Inst Pharmakol & Toxikol, D-01109 Dresden, Germany
[4] Univ Cambridge, Physiol Lab, Cambridge CB2 3EG, England
关键词
putative beta(4)-adrenoceptor and beta(1)-adrenoceptor; mouse ventricular myocytes; calcium transients; calcium current; arrhythmias (-)-CGP 12177 and (-)-isoprenaline;
D O I
10.1007/s002109900075
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Putative beta(4)-adrenoceptors mediate cardiostimulation and arrhythmias in mammalian heart. Both beta(1)- and putative beta(4)-adrenoceptors mediate arrhythmias but through different mechanisms. To elucidate further the mechanisms of cardiostimulation and arrhythmias we measured Ca2+ transients and L-type Ca2+ currents in mouse ventricular myocytes, We used (-)-CGP 12177, an antagonist of beta(1)- and beta(2)-adrenoceptors with agonist properties at the putative beta(4)-adrenoceptor, and (-)-isoprenaline as an agonist for beta(1)- and beta(2)-adrenoceptors, (-)-CGP 12177 increased Ca2+ transients in electrically stimulated cells loaded with Indo-1. The maximum increase of Ca2+ transients caused by (-)-CGP 12177 amounted to approximately one-third of that caused by maximally effective (-)-isoprenaline concentrations. Both (-)-CGP 12177 and (-)-isoprenaline caused concentration-dependent arrhythmic Ca2+ transients. The arrhythmias appeared at paced Ca2+ transients and between paced Ca2+ transients. The arrhythmic potency of (-)-CGP 12177 (-logEC(50) = 9.4) was approximately 40 times greater than that of (-)-isoprenaline (-logEC(50) = 7.8). L-type Ca2+ current was measured in the whole cell configuration of the patch clamp technique. In the presence of both 3-isobutyl 1-methylxanthine (6 mu mol/l) and (-)-propranolol (500 nmol/l), (-)-CGP 12177 (100 nmol/l) increased significantly L-type Ca2+ current by 19% of the effect of (-)-isoprenaline. The (-)-CGP 12177-evoked increase of Ca2+ transients contrasts with the smaller effects on L-type Ca2+ current, suggesting that activation of the putative beta(4)-adrenoceptor causes a more efficient Ca2+-induced Ca2+ release than activation of the beta(1)-adrenoceptor. beta(4)-Adrenoceptors mediate arrhythmias with smaller Ca2+ transients and smaller increases of L-type Ca2+ current than beta(1)-adrenoceptors, in line with different but still unknown mechanisms as previously suggested for the intact heart.
引用
收藏
页码:445 / 456
页数:12
相关论文
共 46 条
[31]   Mediation of the positive chronotropic effect of CGP 12177 and cyanopindolol in the pithed rat by atypical beta-adrenoceptors, different from beta(3)-adrenoceptors [J].
Malinowska, B ;
Schlicker, E .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 (05) :943-949
[32]   ACTIVATION OF CALCIUM CURRENTS IN CARDIAC MYOCYTES BY EMPTY BETA-ADRENOCEPTORS [J].
MEWES, T ;
DUTZ, S ;
RAVENS, U ;
JAKOBS, KH .
CIRCULATION, 1993, 88 (06) :2916-2922
[33]   Proposal for the interaction of non-conventional partial agonists and catecholamines with the 'putative beta(4)-adrenoceptor' in mammalian heart [J].
Molenaar, P ;
Sarsero, D ;
Kaumann, AJ .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1997, 24 (9-10) :647-656
[34]  
NANOFF C, 1987, N-S ARCH PHARMACOL, V336, P519
[35]   Anomalous behavior of CGP 12177A on beta(1)-adrenergic receptors [J].
Pak, MD ;
Fishman, PH .
JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH, 1996, 16 (1-2) :1-23
[36]   Targeted disruption of the mouse beta 1-adrenergic receptor gene: Developmental and cardiovascular effects [J].
Rohrer, DK ;
Desai, KH ;
Jasper, JR ;
Stevens, ME ;
Regula, DP ;
Barsh, GS ;
Bernstein, D ;
Kobilka, BK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (14) :7375-7380
[37]   Validity of (-)-[3H]-CGP 12177A as a radioligand for the 'putative β4-adrenoceptor' in rat atrium [J].
Sarsero, D ;
Molenaar, P ;
Kaumann, AJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 (03) :371-380
[38]  
Sarsero D, 1998, N-S ARCH PHARMACOL, V358, pR629
[39]  
SARSERO D, 1996, J MOL CELL CARDIOL, V28, pA274
[40]  
Sennitt MV, 1998, J PHARMACOL EXP THER, V285, P1084